Main Article Content
Introduction: Diabetes mellitus (DM), belongs to the elegance of metabolic sicknesses which the mainsymptom related to this disorder is the excessive sugar ranges in blood for a protracted period. It may be categorised to the world’s principal sicknesses thinking about that influences excessive populace in earth and affords principal sorts I and II. Diabetes headaches include viable blindness, amputation of decrease limb, renal failure, and cardiac arrest or stroke. This evaluate summarizes the pathophysiology for each kinds of DM, the type of antidiabetic medicinal drugs in addition to destiny perspectives. Until now injectable medicinal drugs are greater regularly used which will acquire the proper remedy. Patients choose oral antidiabetic medicinal drugs given that are less complicated to be administered and for that reason researchers consciousness their research at this direction. This paintings additionally aimed to provide and compare viable oral formulations towards DM kind II.
Methodology: Data from 50 no of Patient with Diabetes on the Outpatient of VIMSAR,Burla changed into gathered in step with element Semistructure questionary. The Data encompass Demographic facts and Prescription survey Regarding Drug Prescription Patteren and Drug Utilisation Patteren.
Results and Discussion: In the existing Study amongst Participants the male percent changed into a great deal greater. More male patient. Metformin changed into the maximum famous and regularly prescribed drug for Patient coming to inpatient department. Beside this Sulfonylurea organization is the every other drug prescribed to massive no of Patient.
Conclusion: To acquire most reliable glycemic control, The efficacy of Antidiabetic drug changed into simplest 40% Satisfactory. Hence intensification of modern-day drug remedy in addition to making plans more than one drug remedy with changed way of life justify closer to a hit oral anti diabetic therapy.
Okur ME, Karantas ID, Siafaka PI. Diabetes Mellitus: a review on pathophysiology, current status of oral pathophysiology, current status of oral medications and future perspectives. ACTA Pharmaceutica Sciencia. 2017;55(1).
Garatini S, Paoleti R, Bizzi L, Gmssi E, Vertua A. In Drugs affecting lipid metabolism. Elsvier, Amstardam. 1961;1- 44.
Geddes R. Glycogen: A metabolic view point. Bioscience Rep. 1986;6:415.
Gerich JE, Campbell PJ. Overview of counter egutation and its abnormalities in diabetes mellitus and other conditions. Diabetes Metlab Rev. 1988;4: 93-111.
Granner DK. Hormones of the pancreas and gastrointestinal tract, Harper's Biochemistry, 25th Ed. 2000;610-626.
Howard BV, Howard WMJ. The pathophysiology and treatment of lipid disorders in diabetes mellitus. In. Joslin's Diabetes Mellitus, 1T Ed. (1st Ind Ed.), B.I. Waverly Pvt. Ltd., New Delhi. 1996;372-396.
Jacobe NJ, Van Demark PJ. Arch. Biochem Biophys. 1960;88:250.
Jain AK, Mehta SC, Shrivastava NM. Hypoglycemia and antihyperglycernic effects of newly synthesized sulfonyloxy derivatives of azalactone in normal and alloxan diabetic rabbits. Ind J Pharmcol Dec. 2005;37(6):395- 396.
Jenson AB, Rosenberg HS, Notkins AL. Pancreatic islet cell damage in children with fatal viral infection. Lancet. 1980;2:354-8.
Pandey A, Tripathi P, Pandey R, Srivastava R, Pandey A. Drug utilization study in diabetic patients. Int J Biomed Res Anal. 2010;1:38– 40.
Singh R, Tuli A, Madan J, Kaur M, Singh Rao H. Role of pharmacist in structured teaching programme on self-care managementof diabetes mellitus. Ind Pharm. 2008;7:59–61.
Mishra MK, Panda BB, Ghosh G, Mishra SK, Barik BB.Emerging trends in the management of diabetes: an overview. Indian Drugs 2008; 45:441–6.
Sultana S, Hamid K, Islam KM, Roy S, Saha MR, Zulfi ker AH, et al. Assessment of prescription pattern of hypertensive patients ’prescription: a prescription survey study from various hospitals of Bangladesh. Eur J Sci Res. 2010;40:500–5.
Subhasish S, Kaushik DK, Sabita S, Debasish S. Prescriptionanalysis in diabetes mellitus. Int J Pharm Biosci. 2010;V1:1–8.
Adibe MO, Aguwa CN, Ukwe CV, Okonta JM, Udeogaranya PO. Outpatient utilization of antidiabetic drugs in south eastern Nigeria. Int J Drug Dev Res. 2009;1:27–36.
Kamrai D, Sachdeva P. Prescribing trends of antidiabeticsin diabetic patients and hypertensive diabetic patients in anurban secondary care hospital. Int J Pharm Biol Arch. 2010;1:249–55.
Hassan Y, Mathialagan A, Awaisu A, Abd. Aziz N, Yahaya R, Salhani A. Trend in the use of oral hypoglycemic agents in anoutpatient pharmacy departmentof a tertiary hospital in Malaysia (2003 – 2006). Asian J Pharm Clin Res. 2009;2:40–6.
Most read articles by the same author(s)
- BISWARANJAN RAY, ASHOK KUMAR PANIGRAHI, SULOCHANA DUTTA, MONALISA GOCHAYAT, COMPUTER AIDED DRUG DESIGN: TOOLS TO DEVELOP DRUG FOR COVID 19 , Asian Journal of Advances in Medical Science: 2021 - Volume 3 [Issue 4]